497 related articles for article (PubMed ID: 32962696)
1. The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome.
Lee HC; Shin SJ; Huang JK; Lin MY; Lin YH; Ke LY; Jiang HJ; Tsai WC; Chao MF; Lin YH
Lipids Health Dis; 2020 Sep; 19(1):210. PubMed ID: 32962696
[TBL] [Abstract][Full Text] [Related]
2. The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome.
Lee HC; Lin YH
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019138
[TBL] [Abstract][Full Text] [Related]
3. Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study.
Hosseinpanah F; Nazeri P; Ghareh S; Tohidi M; Azizi F
Eur J Clin Nutr; 2014 Mar; 68(3):295-9. PubMed ID: 23963276
[TBL] [Abstract][Full Text] [Related]
4. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
6. Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study.
Nyström PK; Carlsson AC; Leander K; de Faire U; Hellenius ML; Gigante B
PLoS One; 2015; 10(5):e0127111. PubMed ID: 25978738
[TBL] [Abstract][Full Text] [Related]
7. HDL-C, ApoA1 and VLDL-TG as biomarkers for the carotid plaque presence in patients with metabolic syndrome.
Abi-Ayad M; Abbou A; Abi-Ayad FZ; Behadada O; Benyoucef M
Diabetes Metab Syndr; 2018; 12(2):175-179. PubMed ID: 29338972
[TBL] [Abstract][Full Text] [Related]
8. Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia.
Loke SS; Yang KD; Chen KD; Chen JF
World J Gastroenterol; 2013 Sep; 19(35):5883-8. PubMed ID: 24124334
[TBL] [Abstract][Full Text] [Related]
9. Adiposity measurements in association with metabolic syndrome in older men have different clinical implications.
Hsu CH; Lin JD; Hsieh CH; Lau SC; Chiang WY; Chen YL; Pei D; Chang JB
Nutr Res; 2014 Mar; 34(3):219-25. PubMed ID: 24655488
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome associates with left atrial dysfunction.
Nyman K; Granér M; Pentikäinen MO; Lundbom J; Hakkarainen A; Sirén R; Nieminen MS; Taskinen MR; Lundbom N; Lauerma K
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):727-734. PubMed ID: 29764718
[TBL] [Abstract][Full Text] [Related]
11. Association of lipid composition and unsaturated fatty acids of VLDL with atrial remodeling in metabolic syndrome.
Lee HC; Cheng WC; Ma WL; Lin YH; Shin SJ; Lin YH
Sci Rep; 2023 Apr; 13(1):6575. PubMed ID: 37085694
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS.
Wood AC; Glasser S; Garvey WT; Kabagambe EK; Borecki IB; Tiwari HK; Tsai MY; Hopkins PN; Ordovas JM; Arnett DK
Lipids Health Dis; 2011 Aug; 10():143. PubMed ID: 21854610
[TBL] [Abstract][Full Text] [Related]
13. The Relationship of Functional Status of Cortisol, Testosterone, and Parameters of Metabolic Syndrome in Male Schizophrenics.
Han Y; Ji H; Liu L; Zhu Y; Jiang X
Biomed Res Int; 2020; 2020():9124520. PubMed ID: 33150186
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population.
Stefansson VTN; Schei J; Solbu MD; Jenssen TG; Melsom T; Eriksen BO
Kidney Int; 2018 May; 93(5):1183-1190. PubMed ID: 29395334
[TBL] [Abstract][Full Text] [Related]
15. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
Fu ZF; Liu ML
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
[TBL] [Abstract][Full Text] [Related]
16. Association of
Rana S; Sultana A; Bhatti AA
J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502573
[TBL] [Abstract][Full Text] [Related]
17. A clustering analysis of lipoprotein diameters in the metabolic syndrome.
Frazier-Wood AC; Glasser S; Garvey WT; Kabagambe EK; Borecki IB; Tiwari HK; Tsai MY; Hopkins PN; Ordovas JM; Arnett DK
Lipids Health Dis; 2011 Dec; 10():237. PubMed ID: 22182248
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance.
Salazar MR; Carbajal HA; Espeche WG; Leiva Sisnieguez CE; March CE; Balbín E; Dulbecco CA; Aizpurúa M; Marillet AG; Reaven GM
Diab Vasc Dis Res; 2013 Jul; 10(4):346-52. PubMed ID: 23624761
[TBL] [Abstract][Full Text] [Related]
19. Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease.
Yamaoka-Tojo M; Tojo T; Takahira N; Matsunaga A; Aoyama N; Masuda T; Izumi T
Cardiovasc Diabetol; 2010 May; 9():17. PubMed ID: 20470376
[TBL] [Abstract][Full Text] [Related]
20. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
